Latest filing published 19 May 2022 for Exicure, INC., €270k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Bali Muralidhar: trading record in brief
This profile gathers the share dealings of Bali Muralidhar across 3 companies, led by OnKure Therapeutics, Inc., Exicure, Inc. and Spruce Biosciences, Inc. The record holds 16 filings, for trades running from 19 December 2019 to 19 May 2022.
Every open-market trade on record is a purchase: 14 purchases worth €8.7M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2022 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €145k. 2 out of 14 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 19 May 2022, the filings show an open-market purchase worth €270k in Exicure, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Bali Muralidhar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,472,126 shares@ US$0.19370.78% mcap100.0% of flowCommon StockSEC:0001209191-22-030549:0Canonical exit: 17 Aug 2022 (T+90)
- 111,736 shares@ US$8.5054.3% of flowCommon StockSEC:0001209191-21-046803:0Canonical exit: 12 Oct 2021 (T+90)
- 20,710 shares@ US$9.282710.9% of flowCommon StockSEC:0000905718-21-000834:0Canonical exit: 21 Sept 2021 (T+90)
- 32,659 shares@ US$9.030516.7% of flowCommon StockSEC:0000905718-21-000816:0Canonical exit: 19 Sept 2021 (T+90)
- 16,605 shares@ US$9.49778.8% of flowCommon StockSEC:0000905718-21-000770:0Canonical exit: 6 Sept 2021 (T+90)
- 12,100 shares@ US$9.25156.2% of flowCommon StockSEC:0000905718-21-000760:0Canonical exit: 1 Sept 2021 (T+90)
- 14 shares@ US$9.500.0% of flowCommon StockSEC:0000905718-21-000744:0Canonical exit: 26 Aug 2021 (T+90)
- 5,915 shares@ US$9.38213.1% of flowCommon StockSEC:0000905718-21-000738:0Canonical exit: 24 Aug 2021 (T+90)
8 of 8 declarations
